2023 ASTRO Annual Meeting

Visit us at booth 2425 in the Exhibit Hall.

Astro Michalski

Jeff Michalski, MD, addresses ASTRO

Jeff M. Michalski, MD, MBA, FASTRO, is the Carlos A. Perez Distinguished Professor and Vice Chair and Director of Clinical Programs at Washington University School of Medicine in St. Louis. He currently serves as President of ASTRO.

During his tenure as President, Dr. Michalski has been focusing on the Society’s priority issues, including safeguarding equitable patient access to lifesaving cancer treatment; building a pipeline of diverse radiation oncology clinicians and researchers; and developing programs and policies that will prepare the future workforce to meet the evolving cancer care landscape.

090123 2023 Astro Conf Display Final

Washington University Department of Radiation Oncology

The Washington University Department of Radiation Oncology, one of the largest in the United States, is nationally renowned for developing the latest radiation treatments for cancer patients. We offer the widest range of radiation therapy options in the Midwest, allowing our physicians to tailor treatment to each individual patient’s needs. We are a national leader in radiation oncology clinical trials, hold many leadership positions in cooperative groups and National Cancer Institute steering committees, and rank as the highest academic accrual site for cooperative group therapeutic trials. The department’s clinical programs consist of several centers of excellence including brachytherapy, stereotactic radiosurgery, adaptive radiation therapy and the S. Lee Kling Proton Therapy Center.

Siteman Physician Directory
Proton Front Rad Onc

Clinical Trials at Siteman

At Siteman, patients have access to more than 500 therapeutic clinical trials, including many collaborative efforts with our colleagues throughout the country.

View trials

Connect With Us

If you want to start a referral for treatment or a clinical trial, give us a call or fill out our web form. To stay in contact and receive the latest Siteman news and clinical trials, sign-up for our e-newsletter.